Medigene (OTC:MDGEF) Stock, Quote.Headers.trade-ideas

Medigene AG is an immuno-oncology biotechnology company. focused on developing differentiated T Cell Receptor engineered T cell (TCR-T) therapies for the treatment of multiple solid tumor indications with a high unmet medical need. The operating segments of the organization are Immunotherapies and Other products. Immunotherapies consist of T-cell receptor-based adoptive T-cell therapy and DC vaccines. The group operates in the United States, Germany, and Asia, of which the majority of the revenue is derived from operations in Germany.

Analyst Color

Biotech

Long Ideas

News

Health Care

Reiteration

Exclusives

Analyst Ratings

Trading Ideas

Interview

General

BLUE

MDGEF

PowerShares ETF Trust Dynamic Biotech & Genome Port

SBIO

Exclusive: SunTrust Managing Director Discusses Bluebird Bio, A Leader In Gene Therapy

Comments

Medigene

Medigene (OTC:MDGEF) Stock, Quote.Headers.trade-ideas

Connect With Us

About Benzinga

Market Resources

Trading Tools & Education

Ring the Bell